[{"edinetCode":"E30445","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":78.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":3014700.0,"sharesOwendPercent":0.5524,"outstandingShares":null,"numberOfSubsidiary":8.0,"bps":449.67,"equityRatio":0.202,"cashAndCashEquivalents":1342881000.0,"assets":12123475000.0,"currentAssets":4850374000.0,"fixedAsset":7239539000.0,"tangibleFixedAssets":5435665000.0,"intangibleFixedAssets":492614000.0,"investmentAndOtherAssets":1311259000.0,"liabilities":9519746000.0,"currentLiabilities":3456902000.0,"shorTermDept":942365000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1048557000.0,"fixedLiabilities":6062843000.0,"bonds":371500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5270134000.0,"netAsset":2603729000.0,"capitalStock":2563589000.0,"capital":922457000.0,"capitalSurplus":994604000.0,"accumulatedEarnings":646594000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-109670000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":5347892000.0,"costOfSales":4150040000.0,"grossProfit":1197852000.0,"sgaExpenses":940850000.0,"salaryAndBenefit":256235000.0,"depreciationAndSGA":null,"RDExpenses":21311000.0,"operatingIncome":257001000.0,"nonOperatingIncome":8063000.0,"nonOperatingExpenses":166674000.0,"interestExpense":88372000.0,"ordinaryProfit":98391000.0,"extraordinaryGain":17000.0,"extraordinaryLoss":109000.0,"incomeBeforeTax":98299000.0,"incomeTaxes":48987000.0,"netIncome":49311000.0,"netIncomeAttributableToOwnersOfTheParentCompany":20711000.0,"comprehensiveIncome":-80227000.0,"eps":3.8,"dilutedEps":3.67,"dividendPerShare":null,"per":179.74,"roe":0.008,"cashFlowFromOperatingActivities":170174000.0,"depreciationAndCashflowFromOperatingActivities":174963000.0,"cashFlowFromInvestingActivities":-3955414000.0,"cashFlowFromFinancialActivities":3037707000.0,"changesInCashAndCashEquivalents":-751198000.0,"列1":"asr","submitDate":"2017\/6\/26","stockCode":6092,"accountingYear":"第18期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":83.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":3004900.0,"sharesOwendPercent":0.4667,"outstandingShares":null,"numberOfSubsidiary":9.0,"bps":699.34,"equityRatio":0.236,"cashAndCashEquivalents":3347344000.0,"assets":19088269000.0,"currentAssets":7577335000.0,"fixedAsset":11485283000.0,"tangibleFixedAssets":9642399000.0,"intangibleFixedAssets":834669000.0,"investmentAndOtherAssets":1008215000.0,"liabilities":14580631000.0,"currentLiabilities":4321914000.0,"shorTermDept":1827200000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":618343000.0,"fixedLiabilities":10258716000.0,"bonds":316500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":9403154000.0,"netAsset":4507638000.0,"capitalStock":4623830000.0,"capital":1756434000.0,"capitalSurplus":1832017000.0,"accumulatedEarnings":1035445000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-121021000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":8388048000.0,"costOfSales":6497007000.0,"grossProfit":1891040000.0,"sgaExpenses":1103995000.0,"salaryAndBenefit":277202000.0,"depreciationAndSGA":null,"RDExpenses":13306000.0,"operatingIncome":787044000.0,"nonOperatingIncome":64600000.0,"nonOperatingExpenses":182778000.0,"interestExpense":131665000.0,"ordinaryProfit":668867000.0,"extraordinaryGain":77000.0,"extraordinaryLoss":17315000.0,"incomeBeforeTax":651628000.0,"incomeTaxes":245144000.0,"netIncome":406483000.0,"netIncomeAttributableToOwnersOfTheParentCompany":403951000.0,"comprehensiveIncome":396326000.0,"eps":70.62,"dilutedEps":67.81,"dividendPerShare":null,"per":29.16,"roe":0.116,"cashFlowFromOperatingActivities":791201000.0,"depreciationAndCashflowFromOperatingActivities":330664000.0,"cashFlowFromInvestingActivities":-4613100000.0,"cashFlowFromFinancialActivities":5813454000.0,"changesInCashAndCashEquivalents":1994336000.0,"列1":"asr","submitDate":"2018\/6\/25","stockCode":6092,"accountingYear":"第19期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":81.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2887595.0,"sharesOwendPercent":0.4443,"outstandingShares":null,"numberOfSubsidiary":9.0,"bps":665.95,"equityRatio":0.239,"cashAndCashEquivalents":2181846000.0,"assets":18081236000.0,"currentAssets":6963693000.0,"fixedAsset":11100333000.0,"tangibleFixedAssets":9519406000.0,"intangibleFixedAssets":649155000.0,"investmentAndOtherAssets":931770000.0,"liabilities":13752419000.0,"currentLiabilities":3960580000.0,"shorTermDept":1713000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":952987000.0,"fixedLiabilities":9791838000.0,"bonds":161500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":9072704000.0,"netAsset":4328817000.0,"capitalStock":4487708000.0,"capital":1762534000.0,"capitalSurplus":1841118000.0,"accumulatedEarnings":884122000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-159588000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":8563053000.0,"costOfSales":6585426000.0,"grossProfit":1977626000.0,"sgaExpenses":1344164000.0,"salaryAndBenefit":314746000.0,"depreciationAndSGA":null,"RDExpenses":90009000.0,"operatingIncome":633461000.0,"nonOperatingIncome":12845000.0,"nonOperatingExpenses":210411000.0,"interestExpense":148764000.0,"ordinaryProfit":435896000.0,"extraordinaryGain":130000.0,"extraordinaryLoss":496307000.0,"incomeBeforeTax":-60280000.0,"incomeTaxes":94676000.0,"netIncome":-154957000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-150957000.0,"comprehensiveIncome":-193524000.0,"eps":-23.35,"dilutedEps":null,"dividendPerShare":null,"per":-27.28,"roe":-0.034,"cashFlowFromOperatingActivities":-390619000.0,"depreciationAndCashflowFromOperatingActivities":492904000.0,"cashFlowFromInvestingActivities":-638086000.0,"cashFlowFromFinancialActivities":-153806000.0,"changesInCashAndCashEquivalents":-1183656000.0,"列1":"asr","submitDate":"2019\/6\/24","stockCode":6092,"accountingYear":"第20期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.323,"cashAndCashEquivalents":null,"assets":14797426000.0,"currentAssets":7364446000.0,"fixedAsset":7417879000.0,"tangibleFixedAssets":5527619000.0,"intangibleFixedAssets":639093000.0,"investmentAndOtherAssets":1251165000.0,"liabilities":10003120000.0,"currentLiabilities":3635584000.0,"shorTermDept":1542300000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":695670000.0,"fixedLiabilities":6367535000.0,"bonds":147500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5764705000.0,"netAsset":4794306000.0,"capitalStock":4912230000.0,"capital":1786284000.0,"capitalSurplus":1864868000.0,"accumulatedEarnings":1261145000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-133481000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2154239000.0,"costOfSales":1444446000.0,"grossProfit":709793000.0,"sgaExpenses":361853000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":347940000.0,"nonOperatingIncome":6239000.0,"nonOperatingExpenses":71436000.0,"interestExpense":45685000.0,"ordinaryProfit":282743000.0,"extraordinaryGain":606829000.0,"extraordinaryLoss":298126000.0,"incomeBeforeTax":591446000.0,"incomeTaxes":218744000.0,"netIncome":372702000.0,"netIncomeAttributableToOwnersOfTheParentCompany":377449000.0,"comprehensiveIncome":398808000.0,"eps":58.0,"dilutedEps":57.31,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":6092,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2864397.0,"sharesOwendPercent":0.436,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.327,"cashAndCashEquivalents":3323312000.0,"assets":14971905000.0,"currentAssets":7286997000.0,"fixedAsset":7671918000.0,"tangibleFixedAssets":5629406000.0,"intangibleFixedAssets":631660000.0,"investmentAndOtherAssets":1410851000.0,"liabilities":10057540000.0,"currentLiabilities":4451978000.0,"shorTermDept":1522300000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1293737000.0,"fixedLiabilities":5605562000.0,"bonds":134000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5071519000.0,"netAsset":4914364000.0,"capitalStock":5059205000.0,"capital":1786284000.0,"capitalSurplus":1864868000.0,"accumulatedEarnings":1408119000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-157429000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":4287952000.0,"costOfSales":2951003000.0,"grossProfit":1336948000.0,"sgaExpenses":710011000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":626937000.0,"nonOperatingIncome":9157000.0,"nonOperatingExpenses":117239000.0,"interestExpense":74725000.0,"ordinaryProfit":518854000.0,"extraordinaryGain":608350000.0,"extraordinaryLoss":298126000.0,"incomeBeforeTax":829078000.0,"incomeTaxes":312797000.0,"netIncome":516280000.0,"netIncomeAttributableToOwnersOfTheParentCompany":523996000.0,"comprehensiveIncome":518440000.0,"eps":80.14,"dilutedEps":79.16,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1814987000.0,"depreciationAndCashflowFromOperatingActivities":236739000.0,"cashFlowFromInvestingActivities":3479797000.0,"cashFlowFromFinancialActivities":-4153420000.0,"changesInCashAndCashEquivalents":1141465000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":6092,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.341,"cashAndCashEquivalents":null,"assets":14526859000.0,"currentAssets":7056569000.0,"fixedAsset":7459410000.0,"tangibleFixedAssets":5599686000.0,"intangibleFixedAssets":622971000.0,"investmentAndOtherAssets":1236752000.0,"liabilities":9567466000.0,"currentLiabilities":3924420000.0,"shorTermDept":1110687000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1289422000.0,"fixedLiabilities":5643045000.0,"bonds":120000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5134833000.0,"netAsset":4959393000.0,"capitalStock":5109796000.0,"capital":1786484000.0,"capitalSurplus":1865068000.0,"accumulatedEarnings":1458310000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-150706000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":5747205000.0,"costOfSales":3967143000.0,"grossProfit":1780061000.0,"sgaExpenses":1042558000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":737503000.0,"nonOperatingIncome":17162000.0,"nonOperatingExpenses":157295000.0,"interestExpense":102413000.0,"ordinaryProfit":597370000.0,"extraordinaryGain":608350000.0,"extraordinaryLoss":298126000.0,"incomeBeforeTax":907593000.0,"incomeTaxes":353406000.0,"netIncome":554187000.0,"netIncomeAttributableToOwnersOfTheParentCompany":565945000.0,"comprehensiveIncome":563074000.0,"eps":86.42,"dilutedEps":85.29,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/14","stockCode":6092,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":79.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":3031100.0,"sharesOwendPercent":0.4613,"outstandingShares":null,"numberOfSubsidiary":11.0,"bps":743.42,"equityRatio":0.325,"cashAndCashEquivalents":2951027000.0,"assets":15034071000.0,"currentAssets":7579595000.0,"fixedAsset":7445706000.0,"tangibleFixedAssets":5746711000.0,"intangibleFixedAssets":615226000.0,"investmentAndOtherAssets":1083768000.0,"liabilities":10143476000.0,"currentLiabilities":4593609000.0,"shorTermDept":1493300000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1425807000.0,"fixedLiabilities":5549867000.0,"bonds":106500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5078647000.0,"netAsset":4890594000.0,"capitalStock":5091001000.0,"capital":1786484000.0,"capitalSurplus":1865068000.0,"accumulatedEarnings":1439516000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-205860000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":7408498000.0,"costOfSales":5320876000.0,"grossProfit":2087622000.0,"sgaExpenses":1413432000.0,"salaryAndBenefit":339996000.0,"depreciationAndSGA":null,"RDExpenses":25923000.0,"operatingIncome":674189000.0,"nonOperatingIncome":59580000.0,"nonOperatingExpenses":212373000.0,"interestExpense":130169000.0,"ordinaryProfit":521396000.0,"extraordinaryGain":610850000.0,"extraordinaryLoss":298126000.0,"incomeBeforeTax":834120000.0,"incomeTaxes":301978000.0,"netIncome":532142000.0,"netIncomeAttributableToOwnersOfTheParentCompany":555393000.0,"comprehensiveIncome":485706000.0,"eps":84.74,"dilutedEps":83.64,"dividendPerShare":null,"per":6.61,"roe":0.121,"cashFlowFromOperatingActivities":951622000.0,"depreciationAndCashflowFromOperatingActivities":418571000.0,"cashFlowFromInvestingActivities":3868314000.0,"cashFlowFromFinancialActivities":-4061922000.0,"changesInCashAndCashEquivalents":769180000.0,"列1":"asr","submitDate":"2020\/6\/29","stockCode":6092,"accountingYear":"第21期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.337,"cashAndCashEquivalents":null,"assets":15344969000.0,"currentAssets":6428746000.0,"fixedAsset":8909563000.0,"tangibleFixedAssets":7244730000.0,"intangibleFixedAssets":606219000.0,"investmentAndOtherAssets":1058613000.0,"liabilities":10139666000.0,"currentLiabilities":3209882000.0,"shorTermDept":1366300000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":929496000.0,"fixedLiabilities":6929783000.0,"bonds":92500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6481852000.0,"netAsset":5205303000.0,"capitalStock":5362465000.0,"capital":1786484000.0,"capitalSurplus":1865068000.0,"accumulatedEarnings":1710979000.0,"treasuryStock":-66000.0,"valuationAndConversionAdjustments":-191466000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2371449000.0,"costOfSales":1697574000.0,"grossProfit":673875000.0,"sgaExpenses":315716000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":358158000.0,"nonOperatingIncome":75611000.0,"nonOperatingExpenses":46277000.0,"interestExpense":29631000.0,"ordinaryProfit":387492000.0,"extraordinaryGain":11399000.0,"extraordinaryLoss":null,"incomeBeforeTax":398892000.0,"incomeTaxes":99397000.0,"netIncome":299494000.0,"netIncomeAttributableToOwnersOfTheParentCompany":270643000.0,"comprehensiveIncome":314052000.0,"eps":41.19,"dilutedEps":40.76,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/12","stockCode":6092,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2957275.0,"sharesOwendPercent":0.4496,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.342,"cashAndCashEquivalents":2716959000.0,"assets":15133836000.0,"currentAssets":6128505000.0,"fixedAsset":9000781000.0,"tangibleFixedAssets":7334764000.0,"intangibleFixedAssets":597086000.0,"investmentAndOtherAssets":1068930000.0,"liabilities":9930058000.0,"currentLiabilities":2978590000.0,"shorTermDept":1067300000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1031552000.0,"fixedLiabilities":6951467000.0,"bonds":89000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6487962000.0,"netAsset":5203777000.0,"capitalStock":5356522000.0,"capital":1787334000.0,"capitalSurplus":1865918000.0,"accumulatedEarnings":1703367000.0,"treasuryStock":-96000.0,"valuationAndConversionAdjustments":-182434000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":3621354000.0,"costOfSales":2583528000.0,"grossProfit":1037825000.0,"sgaExpenses":627319000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":410505000.0,"nonOperatingIncome":77595000.0,"nonOperatingExpenses":105309000.0,"interestExpense":62083000.0,"ordinaryProfit":382792000.0,"extraordinaryGain":11899000.0,"extraordinaryLoss":null,"incomeBeforeTax":394692000.0,"incomeTaxes":106604000.0,"netIncome":288087000.0,"netIncomeAttributableToOwnersOfTheParentCompany":263850000.0,"comprehensiveIncome":311677000.0,"eps":40.15,"dilutedEps":39.73,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":781268000.0,"depreciationAndCashflowFromOperatingActivities":179382000.0,"cashFlowFromInvestingActivities":-1568596000.0,"cashFlowFromFinancialActivities":563230000.0,"changesInCashAndCashEquivalents":-234068000.0,"列1":"q2r","submitDate":"2020\/11\/13","stockCode":6092,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.332,"cashAndCashEquivalents":null,"assets":15777443000.0,"currentAssets":6765407000.0,"fixedAsset":9008701000.0,"tangibleFixedAssets":7356987000.0,"intangibleFixedAssets":588303000.0,"investmentAndOtherAssets":1063410000.0,"liabilities":10504221000.0,"currentLiabilities":3052799000.0,"shorTermDept":695300000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1163217000.0,"fixedLiabilities":7451422000.0,"bonds":75000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7024962000.0,"netAsset":5273221000.0,"capitalStock":5419785000.0,"capital":1787334000.0,"capitalSurplus":1865918000.0,"accumulatedEarnings":1766630000.0,"treasuryStock":-96000.0,"valuationAndConversionAdjustments":-177474000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":5491252000.0,"costOfSales":3974326000.0,"grossProfit":1516925000.0,"sgaExpenses":965528000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":551397000.0,"nonOperatingIncome":87553000.0,"nonOperatingExpenses":150845000.0,"interestExpense":93051000.0,"ordinaryProfit":488104000.0,"extraordinaryGain":11899000.0,"extraordinaryLoss":0.0,"incomeBeforeTax":500004000.0,"incomeTaxes":147434000.0,"netIncome":352570000.0,"netIncomeAttributableToOwnersOfTheParentCompany":327114000.0,"comprehensiveIncome":380956000.0,"eps":49.76,"dilutedEps":49.25,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":6092,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":81.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2906288.0,"sharesOwendPercent":0.4372,"outstandingShares":null,"numberOfSubsidiary":11.0,"bps":795.22,"equityRatio":0.337,"cashAndCashEquivalents":1985292000.0,"assets":15698580000.0,"currentAssets":6615693000.0,"fixedAsset":9080322000.0,"tangibleFixedAssets":7332223000.0,"intangibleFixedAssets":580285000.0,"investmentAndOtherAssets":1167814000.0,"liabilities":10381400000.0,"currentLiabilities":3028014000.0,"shorTermDept":955300000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1050209000.0,"fixedLiabilities":7353385000.0,"bonds":71500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6959732000.0,"netAsset":5317179000.0,"capitalStock":5411081000.0,"capital":1794509000.0,"capitalSurplus":1873093000.0,"accumulatedEarnings":1743576000.0,"treasuryStock":-96000.0,"valuationAndConversionAdjustments":-124781000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":6840611000.0,"costOfSales":4950646000.0,"grossProfit":1889964000.0,"sgaExpenses":1272060000.0,"salaryAndBenefit":323668000.0,"depreciationAndSGA":null,"RDExpenses":8224000.0,"operatingIncome":617904000.0,"nonOperatingIncome":149342000.0,"nonOperatingExpenses":174782000.0,"interestExpense":125511000.0,"ordinaryProfit":592464000.0,"extraordinaryGain":11899000.0,"extraordinaryLoss":116053000.0,"incomeBeforeTax":488310000.0,"incomeTaxes":157137000.0,"netIncome":331173000.0,"netIncomeAttributableToOwnersOfTheParentCompany":304060000.0,"comprehensiveIncome":410565000.0,"eps":46.22,"dilutedEps":45.76,"dividendPerShare":null,"per":13.89,"roe":0.06,"cashFlowFromOperatingActivities":297156000.0,"depreciationAndCashflowFromOperatingActivities":359172000.0,"cashFlowFromInvestingActivities":-2159510000.0,"cashFlowFromFinancialActivities":928537000.0,"changesInCashAndCashEquivalents":-965735000.0,"列1":"asr","submitDate":"2021\/6\/28","stockCode":6092,"accountingYear":"第22期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.348,"cashAndCashEquivalents":null,"assets":15641480000.0,"currentAssets":6586879000.0,"fixedAsset":9052805000.0,"tangibleFixedAssets":7295276000.0,"intangibleFixedAssets":571123000.0,"investmentAndOtherAssets":1186405000.0,"liabilities":10165579000.0,"currentLiabilities":2989939000.0,"shorTermDept":1016000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":948992000.0,"fixedLiabilities":7175639000.0,"bonds":57500000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6774615000.0,"netAsset":5475901000.0,"capitalStock":5569091000.0,"capital":1796809000.0,"capitalSurplus":1875393000.0,"accumulatedEarnings":1940834000.0,"treasuryStock":-43945000.0,"valuationAndConversionAdjustments":-122909000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":1921231000.0,"costOfSales":1239336000.0,"grossProfit":681895000.0,"sgaExpenses":293637000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":388258000.0,"nonOperatingIncome":42351000.0,"nonOperatingExpenses":34528000.0,"interestExpense":32315000.0,"ordinaryProfit":396081000.0,"extraordinaryGain":304000.0,"extraordinaryLoss":44100000.0,"incomeBeforeTax":352284000.0,"incomeTaxes":112800000.0,"netIncome":239484000.0,"netIncomeAttributableToOwnersOfTheParentCompany":240569000.0,"comprehensiveIncome":241585000.0,"eps":36.23,"dilutedEps":36.18,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/13","stockCode":6092,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2872625.0,"sharesOwendPercent":0.4321,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.352,"cashAndCashEquivalents":3109561000.0,"assets":15863793000.0,"currentAssets":6714901000.0,"fixedAsset":9147866000.0,"tangibleFixedAssets":7406374000.0,"intangibleFixedAssets":562463000.0,"investmentAndOtherAssets":1179027000.0,"liabilities":10248855000.0,"currentLiabilities":3520330000.0,"shorTermDept":667000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1596590000.0,"fixedLiabilities":6728524000.0,"bonds":54000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6347124000.0,"netAsset":5614937000.0,"capitalStock":5732211000.0,"capital":1796809000.0,"capitalSurplus":1876049000.0,"accumulatedEarnings":2074749000.0,"treasuryStock":-15396000.0,"valuationAndConversionAdjustments":-146110000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":4301517000.0,"costOfSales":3009814000.0,"grossProfit":1291703000.0,"sgaExpenses":588823000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":702880000.0,"nonOperatingIncome":62435000.0,"nonOperatingExpenses":91263000.0,"interestExpense":63981000.0,"ordinaryProfit":674052000.0,"extraordinaryGain":304000.0,"extraordinaryLoss":93031000.0,"incomeBeforeTax":581325000.0,"incomeTaxes":208040000.0,"netIncome":373285000.0,"netIncomeAttributableToOwnersOfTheParentCompany":375540000.0,"comprehensiveIncome":352472000.0,"eps":56.62,"dilutedEps":56.58,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1882152000.0,"depreciationAndCashflowFromOperatingActivities":165510000.0,"cashFlowFromInvestingActivities":-373077000.0,"cashFlowFromFinancialActivities":-411275000.0,"changesInCashAndCashEquivalents":1124269000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":6092,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0},{"edinetCode":"E30445","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.365,"cashAndCashEquivalents":null,"assets":15944247000.0,"currentAssets":6507619000.0,"fixedAsset":9436371000.0,"tangibleFixedAssets":7518589000.0,"intangibleFixedAssets":553293000.0,"investmentAndOtherAssets":1364488000.0,"liabilities":10036115000.0,"currentLiabilities":3190410000.0,"shorTermDept":590000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1090669000.0,"fixedLiabilities":6845704000.0,"bonds":40000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6496458000.0,"netAsset":5908132000.0,"capitalStock":5932141000.0,"capital":1796809000.0,"capitalSurplus":1876049000.0,"accumulatedEarnings":2274704000.0,"treasuryStock":-15421000.0,"valuationAndConversionAdjustments":-106343000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":7340548000.0,"costOfSales":5380804000.0,"grossProfit":1959743000.0,"sgaExpenses":889122000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1070621000.0,"nonOperatingIncome":113346000.0,"nonOperatingExpenses":127752000.0,"interestExpense":94034000.0,"ordinaryProfit":1056214000.0,"extraordinaryGain":304000.0,"extraordinaryLoss":96140000.0,"incomeBeforeTax":960378000.0,"incomeTaxes":330175000.0,"netIncome":630203000.0,"netIncomeAttributableToOwnersOfTheParentCompany":580875000.0,"comprehensiveIncome":651073000.0,"eps":87.52,"dilutedEps":87.46,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":6092,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E30445","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1786,"settlementDate":null,"submitterName":"株式会社エンバイオ・ホールディングス","submitterNameEnglish":"EnBio Holdings,Inc","submitterNameKana":"カブシキカイシャエンバイオホールディングス","location":"千代田区鍛冶町二丁目２番２号","industory":"サービス業","corporateNumber":9010000000000.0}]